Search results for "Intravenou"

showing 10 items of 390 documents

SAFETY OF REPEATED MDCT WITH CONTRAST COMPOUND IN CASE OF PREVIOUS MILD OR MODERATE ADVERSE REACTION: A SINGLE CENTRE RETROSPECTIVE STUDY.

2015

Aims and objectives Methods and materials Results Conclusion Personal information References

Drugs / Reactions Safety Contrast agent-intravenous CT Professional issues Contrast agentsgenetic structuresProfessional issuesDrugs / ReactionsSafetyContrast agent-intravenousContrast agentsCT
researchProduct

Intravenous BQ-123 and phosphoramidon reduce ventricular ectopic beats and myocardial infarct size in dogs submitted to coronary occlusion and reperf…

2001

Abstract The aim of this work was to investigate the influence of endothelin on myocardial ischemia and reperfusion in anaesthetized dogs. Animals were submitted to left thoracotomy and 120 min of left anterior descending coronary occlusion, followed by 180 min of reperfusion. Arterial blood pressure and electrocardiogram (ECG) were recorded in order to analyze heart rate (HR)–pressure product and production of ectopic beats. Infarcted areas were identified by a macroscopic staining method and infarct size was expressed as percentage of risk zone. To inhibit the effects of endothelin in a group of animals, we administered intravenously an endothelin synthesis inhibitor (phosphoramidon) and …

Endothelin Receptor Antagonistsmedicine.medical_specialtyMyocardial InfarctionIschemiaBlood PressureCoronary DiseaseMyocardial ReperfusionPeptides Cyclicchemistry.chemical_compoundDogsInternal medicineHeart rateAnimalsMedicinecardiovascular diseasesMyocardial infarctionAntihypertensive AgentsPharmacologyBQ-123Endothelin-1Receptors Endothelinbusiness.industryPhosphoramidonGlycopeptidesReceptor Endothelin Amedicine.diseaseVentricular Premature ComplexesBlood pressurechemistryCoronary occlusionAnesthesiaInjections IntravenousVentricular Fibrillationcardiovascular systemCardiologyDrug Therapy CombinationbusinessEndothelin receptorGeneral Pharmacology: The Vascular System
researchProduct

Cleveland Clinic International IV Robotics Summit

2021

Abstract Disclaimer In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Purpose The proceedings of an international summit on the current and desired future state of use of robotic systems to compound intravenous (IV) solutions are summarized. Summary The International IV Robotics Su…

EngineeringPharmacyintravenous medicationsAutomationPatient safetySAFERHumansPharmacologygeographyMedical educationSummitgeography.geographical_feature_categorybusiness.industryHealth PolicySpecial FeatureRoboticsRoboticsmedication safetyCall to actioncompoundingrobotic technologyRobotic systemsAcademicSubjects/MED00410robotsRobotArtificial intelligencebusinessAmerican Journal of Health-System Pharmacy
researchProduct

Differences in tissue distribution of iron from various clinically used intravenous iron complexes in fetal avian heart and liver.

2015

Abstract Nanomedicines are more complex than most pharmacologically active substances or medicines and have been considered as non-biological complex drugs. For nanomedicines pivotal pharmacokinetic properties cannot be assessed by plasma concentration data from standard bioequivalence studies. Using intravenous iron complexes (IICs) as model we show that fetal avian tissues can be used to study time dependent tissue concentrations in heart and liver. Clear differences were found between equimolar doses of sucrose, gluconate or carboxymaltose coated iron particles. The range in tissue iron concentrations observed with these clinically widely used IICs provides an orientation as to what shou…

FetusExperimental modelbusiness.industryIronTissue ironAuthorizationIntravenous ironHeartGeneral MedicineBioequivalencePharmacologyToxicologyNanomedicineLiverTherapeutic EquivalencyPharmacokineticsAnimalsDrugs GenericMedicineAdministration IntravenousTissue DistributionTissue distributionbusinessChickensIron CompoundsRegulatory Toxicology and Pharmacology
researchProduct

DNA delivery to 'ex vivo' human liver segments.

2011

Hydrodynamic injection is an efficient procedure for liver gene therapy in rodents but with limited efficacy in large animals, using an 'in vivo' adapted regional hydrodynamic gene delivery system. We study the ability of this procedure to mediate gene delivery in human liver segments obtained by surgical resection. Watertight liver segments were retrogradely injected from hepatic vein with a saline solution containing a plasmid bearing the enhanced green fluorescent protein (eGFP) gene, under different conditions of flow rate (1, 10 and 20 ml s(-1)) and final perfused volume. Samples were cultured for 1 to 2 days and used for microscopy and molecular analysis of gene expression. The fluore…

Genetic enhancementGreen Fluorescent ProteinsGene Transfer TechniquesGenetic TherapyBiologyGene deliveryHepatic VeinsMolecular biologyGreen fluorescent proteinCatheterizationLiverIn vivoTranscription (biology)Gene expressionInjections IntravenousGeneticsHydrodynamicsMolecular MedicineHumansMolecular BiologyGeneEx vivoPlasmidsGene therapy
researchProduct

Defective insulin secretory response to intravenous glucose in C57Bl/6J compared to C57Bl/6N mice

2014

Objective: The C57Bl/6J (Bl/6J) mouse is the most widely used strain in metabolic research. This strain carries a mutation in nicotinamide nucleotide transhydrogenase (Nnt), a mitochondrial enzyme involved in NADPH production, which has been suggested to lead to glucose intolerance and beta-cell dysfunction. However, recent reports comparing Bl/6J to Bl/6N (carrying the wild-type Nnt allele) under normal diet have led to conflicting results using glucose tolerance tests. Thus, we assessed glucose-stimulated insulin secretion (GSIS), insulin sensitivity, clearance and central glucose-induced insulin secretion in Bl/6J and N mice using gold-standard methodologies. Methods: GSIS was measured u…

Genetically modified mouseFSIVGTT frequently sampled intravenous glucose tolerance testmedicine.medical_specialtylcsh:Internal medicineinsulin secretionNormal dietDI disposition indexOGTT oral glucose tolerance testmedicine.medical_treatment[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutritionbeta-cellBrief Communicationmedicine.disease_cause[ SDV.BA ] Life Sciences [q-bio]/Animal biologyGSIS glucose-stimulated insulin secretiongenetic backgroundGIR glucose infusion rateInternal medicinemedicineInsulin-degrading enzymeIDE insulin degrading enzymeFood and Nutritioninsulin sensitivityInsulin secretionlcsh:RC31-1245Molecular BiologyEndocrinology and metabolismMutationMI insulin sensitivity indexbusiness.industryInsulin[SDV.BA]Life Sciences [q-bio]/Animal biologyInsulin sensitivityCell BiologyNNT nicotinamide nucleotide transhydrogenaseEndocrinologyIVGTT intravenous glucose tolerance testAlimentation et NutritionEndocrinologie et métabolismemouse strainBeta cellbusiness[SDV.AEN]Life Sciences [q-bio]/Food and Nutritionbeta-cell;insulin secretion;insulin sensitivity;genetic background;mouse strain
researchProduct

Multidisciplinary management of Hunter syndrome.

2009

Hunter syndrome is a rare, X-linked disorder caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase. In the absence of sufficient enzyme activity, glycosaminoglycans accumulate in the lysosomes of many tissues and organs and contribute to the multisystem, progressive pathologies seen in Hunter syndrome. The nervous, cardiovascular, respiratory, and musculoskeletal systems can be involved in individuals with Hunter syndrome. Although the management of some clinical problems associated with the disease may seem routine, the management is typically complex and requires the physician to be aware of the special issues surrounding the patient with Hunter syndrome, and a multidiscipl…

GerontologyAdultMalemedicine.medical_specialtyAdolescentGenotypeIdursulfaseDiseaseIduronate SulfataseYoung AdultInternal medicineAnesthesiologymedicineHumansEnzyme Replacement TherapyCooperative BehaviorIntensive care medicineChildInfusions IntravenousMucopolysaccharidosis IIRandomized Controlled Trials as TopicPatient Care Teambusiness.industryHematopoietic Stem Cell TransplantationInfant NewbornInfantHunter syndromeEnzyme replacement therapymedicine.diseaseCombined Modality TherapyRecombinant ProteinsPulmonologyPhenotypeOtorhinolaryngologyChild PreschoolPediatrics Perinatology and Child HealthInterdisciplinary CommunicationNeurosurgerybusinessmedicine.drugPediatrics
researchProduct

The adenine nucleotide content of rat liver during infusions of carbohydrates and polyols

1972

Injection of large doses of fructose, sorbitol, or a mixture of glucose, fructose and xylitol in rats causes a drop of liver ATP, total adenine nucleotides and Pi and a rise of AMP, which is in agreement with data from the literature. These changes are considered as a transient disturbance of homeostasis by compounds which are rapidly phosporylated in the liver. This is confirmed by the fact that during continuous infusion of these and other compounds at doses of 1,5 g · kg−1 · h−1 there was no such change. It is concluded that infusions of fructose or of the other carbohydrates tested with rates not exceeding those recommended for parenteral nutrition (0,5 g · kg−1 · h−1) are not likely to…

GlycerolMaleParenteral NutritionTime FactorsMedicine (miscellaneous)FructoseXylitolBiochemistryPhosphateschemistry.chemical_compoundAdenosine TriphosphateAdenine nucleotidePiAnimalsHomeostasisSorbitolXylitolAdenine NucleotidesRats Inbred StrainsFructoseAdenosine MonophosphateRatsAdenosine DiphosphateDrug CombinationsGlucoseParenteral nutritionLiverchemistryBiochemistryRat liverInjections IntravenousSorbitolHomeostasisFood ScienceZeitschrift für Ernährungswissenschaft
researchProduct

Inflammation Causes Resistance to Anti-CD20–Mediated B Cell Depletion

2016

B cells play a central role in antibody-mediated rejection and certain autoimmune diseases. However, B cell-targeted therapy such as anti-CD20 B cell-depleting antibody (aCD20) has yielded mixed results in improving outcomes. In this study, we investigated whether an accelerated B cell reconstitution leading to aCD20 depletion resistance could account for these discrepancies. Using a transplantation model, we found that antigen-independent inflammation, likely through toll-like receptor (TLR) signaling, was sufficient to mitigate B cell depletion. Secondary lymphoid organs had a quicker recovery of B cells when compared to peripheral blood. Inflammation altered the pharmacokinetics (PK) and…

Graft RejectionMalemedicine.drug_classInflammation030230 surgeryMonoclonal antibodyArticleLymphocyte DepletionMice03 medical and health sciences0302 clinical medicinemedicineAnimalsImmunologic FactorsImmunology and AllergyPharmacology (medical)ReceptorB cellInflammationB-LymphocytesMice Inbred BALB CTransplantationbiologybusiness.industryGraft SurvivalAlloimmunityImmunoglobulins IntravenousAntigens CD20Mice Inbred C57BLTransplantationmedicine.anatomical_structureImmunologybiology.proteinHeart TransplantationFemaleRituximabAntibodymedicine.symptomRituximabbusiness030215 immunologymedicine.drugAmerican Journal of Transplantation
researchProduct

The binding of intravenous and oral biliary contrast agents to human and bovine serum albumin

1978

The binding of two homologous series of oral and intravenous biliary contrast agents to human and bovine serum albumin was investigated using the gel filtration technique. All intravenous compounds are bound to human serum albumin via one high affinity and several low affinity binding sites. Within the concentration range investigated, about 3--5 high affinity binding sites for the oral compounds were found on human serum albumin. In general, the intravenous compounds have a greater affinity for human serum albumin than the oral compounds. No significant differences were found for the binding of the oral compounds to human or bovine serum albumin, while the intravenous compounds have a high…

High affinity bindingSize-exclusion chromatographySerum albuminAdministration OralContrast MediaPlasma protein bindingIn Vitro TechniquesPharmacologyLow affinitymedicineAnimalsHumansBovine serum albuminBinding siteBiliary TractSerum AlbuminPharmacologyBinding SitesbiologyChemistrySerum Albumin BovineGeneral MedicineHydrogen-Ion ConcentrationHuman serum albuminRadiographySolubilityBiochemistryInjections Intravenousbiology.proteinCattleProtein Bindingmedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct